Comparing DaVita HealthCare Partners (NYSE:DVA) & Its Rivals

DaVita HealthCare Partners (NYSE: DVA) is one of 51 public companies in the “Healthcare Facilities & Services” industry, but how does it compare to its competitors? We will compare DaVita HealthCare Partners to similar companies based on the strength of its risk, profitability, institutional ownership, earnings, valuation, dividends and analyst recommendations.

Risk and Volatility

DaVita HealthCare Partners has a beta of 0.9, meaning that its stock price is 10% less volatile than the S&P 500. Comparatively, DaVita HealthCare Partners’ competitors have a beta of 1.00, meaning that their average stock price is 0% more volatile than the S&P 500.

Analyst Recommendations

This is a breakdown of recent recommendations for DaVita HealthCare Partners and its competitors, as reported by MarketBeat.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
DaVita HealthCare Partners 2 6 2 0 2.00
DaVita HealthCare Partners Competitors 199 1333 1883 35 2.51

DaVita HealthCare Partners presently has a consensus target price of $65.00, indicating a potential upside of 5.64%. As a group, “Healthcare Facilities & Services” companies have a potential downside of 4.60%. Given DaVita HealthCare Partners’ higher possible upside, equities research analysts clearly believe DaVita HealthCare Partners is more favorable than its competitors.

Earnings & Valuation

This table compares DaVita HealthCare Partners and its competitors top-line revenue, earnings per share and valuation.

Gross Revenue EBITDA Price/Earnings Ratio
DaVita HealthCare Partners $15.01 billion $2.45 billion 9.47
DaVita HealthCare Partners Competitors $5.41 billion $832.36 million 22.67

DaVita HealthCare Partners has higher revenue and earnings than its competitors. DaVita HealthCare Partners is trading at a lower price-to-earnings ratio than its competitors, indicating that it is currently more affordable than other companies in its industry.

Insider and Institutional Ownership

82.8% of DaVita HealthCare Partners shares are owned by institutional investors. Comparatively, 69.7% of shares of all “Healthcare Facilities & Services” companies are owned by institutional investors. 2.1% of DaVita HealthCare Partners shares are owned by insiders. Comparatively, 16.0% of shares of all “Healthcare Facilities & Services” companies are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.

Profitability

This table compares DaVita HealthCare Partners and its competitors’ net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
DaVita HealthCare Partners 8.68% 14.02% 3.78%
DaVita HealthCare Partners Competitors 6.84% 0.62% 0.63%

Summary

DaVita HealthCare Partners beats its competitors on 7 of the 13 factors compared.

DaVita HealthCare Partners Company Profile

DaVita Inc., formerly DaVita HealthCare Partners Inc., operates two divisions: DaVita Kidney Care (Kidney Care) and DaVita Medical Group (DMG). The Kidney Care division consists of its the United States dialysis and related lab services, its ancillary services and strategic initiatives, including its international operations, and its corporate administrative support. Its DMG division is a patient- and physician-focused integrated healthcare delivery and management company that provides medical services to members through capitation contracts. Its segments include U.S. dialysis and related lab services, DMG, and Other-Ancillary services and strategic initiatives. Its U.S. dialysis and related lab services line of business provide kidney dialysis services in the United States for patients suffering from chronic kidney failure, also known as end stage renal disease (ESRD). As of December 31, 2016, it had operated or provided administrative services to 154 outpatient dialysis centers.

Receive News & Ratings for DaVita HealthCare Partners Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DaVita HealthCare Partners Inc. and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply